NCT04337346

Brief Summary

It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

April 5, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 7, 2020

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2020

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2020

Completed
Last Updated

May 20, 2020

Status Verified

May 1, 2020

Enrollment Period

15 days

First QC Date

April 5, 2020

Last Update Submit

May 18, 2020

Conditions

EndometriosisCovid19

Outcome Measures

Primary Outcomes (1)

  • Covid 19 Anxiety levels in Endometriosis Patients

    The Beck Anxiety Inventory (BAI); it measures the frequency of anxiety symptoms experienced by the patient. It consists of 21 questions in total. Each item gets an increasing score between 0-3. The total score ranges from 0 - 63. The following guidelines are recommended for the interpretation of scores: 0 -9, normal or no anxiety; 10 -18, mild to moderate anxiety; 19 -29, moderate to severe anxiety; and 30 - 63, severe anxiety.

    20 days

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Evaluation of endometriosis patients anxiety and lifestyle during the covid 19 pandemic

You may qualify if:

  • endometriosis patients
  • no psychiatric illness
  • no antidepressant use

You may not qualify if:

  • women who had not endometriosis
  • no extra health conditions
  • women younger than 18 and older than 45

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pinar Yalcin Bahat

Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

EndometriosisCOVID-19

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
20 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 5, 2020

First Posted

April 7, 2020

Study Start

April 5, 2020

Primary Completion

April 20, 2020

Study Completion

April 25, 2020

Last Updated

May 20, 2020

Record last verified: 2020-05

Locations

TU(1)